← Evidence map

ReviewReviews in endocrine & metabolic disorders2022

The TWEAK/Fn14/CD163 axis-implications for metabolic disease.

Wiktoria Ratajczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34542797